Patents
Patents for C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group (62,773)
02/2011
02/16/2011CN101977504A Fungicide hydroximoyl-tetrazole derivatives
02/16/2011CN101977503A Fungicide hydroximoyl-tetrazole derivatives
02/16/2011CN101973989A Thiazole amide compound and medicinal application thereof for treating malignancy
02/16/2011CN101973988A Method for preparing pioglitazone
02/16/2011CN101973987A Epothilone analogue, preparation method as well as medicine composition and application thereof
02/16/2011CN101973959A 4-methyl-1,2,3-thiadiazole-5-formyl urea compounds and preparation method and application thereof
02/16/2011CN101973957A 5-benzylidene-2,4-thiazolidinedione derivatives and preparation method and application thereof
02/16/2011CN101973934A 1,5-disubstituted aryl-1,4-pentadiene-3-ketoxime ether compound and preparation method thereof and insecticidal activity application
02/16/2011CN101585819B Preparation method for 1,2,3-thiadiazole thioacetanilides derivatives
02/16/2011CN101538245B One-class pyridazinone compounds and preparation method and application thereof
02/16/2011CN101514200B Compound of aztreonam and a synthetic method thereof
02/15/2011US7888504 Glucokinase activators and methods of using same
02/15/2011US7888366 2,4-diaminoquinazolines for spinal muscular atrophy
02/15/2011US7888363 1-Cyclopentyl-3-methyl-2-(2-pyridyl)indole-5-amino/thio/carbonyl derivatives; hepatitis C virus infection; synergistic with another inhibitor of HCV polymerase or immunomodulatory agent such as interferons
02/15/2011US7888344 Fused thiazole derivatives as kinase inhibitors
02/15/2011US7888336 Indole compounds bearing aryl or heteroaryl groups having sphingosine 1-phosphate (S1P) receptor biological activity
02/15/2011CA2633083C Sulfoximine derivatives as p38 map kinase inhibitors
02/15/2011CA2480562C 5-substituted 1,1-dioxo-1,2,5-thiazolidine-3-one derivatives as ptpase 1b inhibitors
02/15/2011CA2480560C .kappa.-opioid receptor agonist comprising 2-phenylbenzothiazoline derivative
02/15/2011CA2452502C 2-(3,5-bis-trifluoromethyl-phenyl)-n-[6-(1,1-dioxo-1.lambda.6-thiomorpholin-4-yl)-4-(2-methyl or 4-fluoro-2-methyl substituted)phenyl-pyridin-3-yl]-n-methyl-isobutyramide
02/15/2011CA2449234C Quinazoline derivatives which promote the release of parathyroid hormone
02/15/2011CA2446864C Inhibitors of src and other protein kinases
02/15/2011CA2444895C Broadspectrum 2-amino-benzoxazole sulfonamide hiv protease inhibitors
02/10/2011WO2011017578A1 Sphingosine-1-phosphate receptor agonists
02/10/2011WO2011017389A1 Macrocyclic serine protease inhibitors useful against viral infections, particularly hcv
02/10/2011WO2011017296A1 4, 5, 6-trisubstituted pyrimidine derivatives as factor ixa inhibitors
02/10/2011WO2011017054A2 Prodrugs of desazadesferrothiocin polyether analogues as metal chelation agents
02/10/2011WO2011016559A1 Heterocyclic compound and use thereof
02/10/2011WO2011016528A1 Aminopyrazole derivative
02/10/2011WO2011016501A1 Prophylactic or therapeutic agent for cancer
02/10/2011WO2011016472A1 Pyridine and pyrimidine derivatives having ttk-inhibiting activity
02/10/2011WO2011015868A1 Enantiomeric resolution method
02/10/2011WO2011015728A1 Novel dihydroindolone derivatives, process for the preparation thereof and pharmaceutical compositions containing same
02/10/2011WO2011015524A2 Fungicide heterocycles derivatives
02/10/2011WO2010148121A3 Benzothiazole derivatives
02/10/2011US20110034694 Compounds having beta2 adrenergic receptor agonist and muscarinic receptor antagonist activity
02/10/2011US20110034689 N4-Phenyl-Quinazoline-4-Amine Derivatives and Related Compounds as ErbB Type I Receptor Tyrosine Kinase Inhibitors for the Treatment of Hyperproliferative Diseases
02/10/2011US20110034517 Selective subtype alpha 2 adrenergic agents and methods for use thereof
02/10/2011US20110034507 Farnesoid x receptor agonists
02/10/2011US20110034449 N-substituted hydroxypyrimidinone carboxamide inhibitors of hiv integrase
02/10/2011US20110034440 Homocysteine synthase inhibitor
02/10/2011US20110034433 4-(4-cyano-2-thioaryl)dihydropyrimidinones and their use
02/10/2011US20110034432 Benzamide derivatives and their use as glucokinase activating agents
02/10/2011US20110034378 Pharmaceutical Combinations Comprising Specified Age Breaker and Further Drugs, I.A. Antihypertensive Drugs, Antidiabetic Drugs Etc.
02/10/2011US20110033560 Preparation and a component intended to be added to a tobacco product
02/10/2011US20110033458 Combinations comprising epothilones and pharmaceutical uses thereof
02/10/2011US20110033457 Combination of epothilone analogs and chemotherapeutic agents for the treatment of proliferative diseases
02/10/2011US20110033417 2,3-substituted indole derivatives for treating viral infections
02/10/2011CA2770195A1 Aminopyrazole derivative
02/10/2011CA2770194A1 Sphingosine-1-phosphate receptor agonists
02/10/2011CA2769652A1 Macrocyclic serine protease inhibitors useful against viral infections, particularly hcv
02/10/2011CA2769245A1 Mesoionic pesticides
02/10/2011CA2768041A1 Prodrugs of desazadesferrothiocin polyether analogues as metal chelation agents
02/09/2011EP2281823A2 Anti-inflammatory and analgesic piperidine derivatives
02/09/2011EP2281822A1 New dihydroindolone derivatives, method of preparing same and pharmaceutical compositions containing them
02/09/2011EP2281818A1 Fused pyridazine derivative compounds and drugs containing these compounds as the active ingredient
02/09/2011EP2281563A1 2,4-Pyrimidinediamine compounds and their uses
02/09/2011EP2281560A1 Inhibitors of glycogen synthase kinase-3 (GSK-3) for treating glaucomatous optic neuropathy
02/09/2011EP2280965A1 Thiazol-4-carboxylic acid esters and thioesters as plant protection agents
02/09/2011EP2280958A1 Hepatitis c virus inhibitors
02/09/2011EP2280941A1 (hetero-)aryl cyclohexane derivatives
02/09/2011EP2280699A1 Novel estrogen receptor ligands
02/09/2011EP2280601A2 Amino acid inhibitors of cytochrome p450
02/09/2011EP2033637B1 Therapeutic or prophylactic agent for leukemia
02/09/2011EP1924579B1 Benzooxazole, oxazolopyridine, benzothiazole and thiazolopyridine derivatives
02/09/2011EP1831184B1 Pyrazines and pyridines and derivatives thereof as therapeutic compounds
02/09/2011EP1685100B1 Novel 1, 3-disubstituted azetidine derivatives for use as 5ht2a receptor ligands
02/09/2011EP1664005B1 Thiazole derivatives as cannabinoid receptor modulators
02/09/2011EP1640367B1 Isoquinoline -1,3,4-trione, the synthetic method and the use thereof
02/09/2011EP1597252B1 Pyridine derivatives as fungicidal compounds
02/09/2011EP1379508B9 N-(aryl)-2-arylethenesulfonamides and therapeutic uses thereof
02/09/2011CN1984901B Substituted 2-quinolyl-oxazoles useful as PDE4 inhibitors.
02/09/2011CN101970432A Fungicidal hetercyclic compounds
02/09/2011CN101970430A Novel pyrimidine derivatives
02/09/2011CN101970426A Indazolyl, benzimidazolyl, benzotriazolyl substituted indolmone derivatives as kinase inhibitors useful in the treatment of cancer
02/09/2011CN101970423A Fungicide hydroximoyl-tetrazole derivatives
02/09/2011CN101970419A Substituted triazinylmethyl sulfonamides
02/09/2011CN101970418A Novel compounds, use and preparation thereof
02/09/2011CN101970417A Substituted pyraz inylmethyl sulfonamides for use as. fungicides
02/09/2011CN101970415A 5h-cyclopenta[d]pyrimidines as akt protein kinase inhibitors
02/09/2011CN101970410A Pyridylaminoacetic acid compound
02/09/2011CN101970409A Uv-filter compounds
02/09/2011CN101970405A Indoles and their therapeutic use
02/09/2011CN101967146A Ep4 receptor inhibitors to treat rheumatoid arthritis
02/09/2011CN101967142A Thiazoleamide compound and medical application thereof in treating malignant tumor
02/09/2011CN101966180A Polymorph of a pharmaceutical
02/09/2011CN101068810B Carbostyril compound
02/08/2011US7884281 Photoelectric transfer material, manufacturing method thereof, photoelectric transfer element and manufacturing method thereof
02/08/2011US7884113 Eating and metabolism disorders; obesity; metabolism disorders; central nervous system disorders; analgesics; antiinflammatory agents; cognition activators
02/08/2011US7883713 Suspension, ointment, solution, spray, lotion, gel, cream, powder, powder spray, paste, emulsion, foam or stick; for treatment of herpes infections in humans
02/08/2011CA2605899C Triazole derivatives as vasopressin antagonists
02/08/2011CA2478068C Dihydropyrazole compounds useful for treating or preventing cancer
02/08/2011CA2464214C Protein kinase and phosphatase inhibitors, methods for designing them, and methods of using them
02/08/2011CA2446924C 2-iminopyrrolidine derivatives
02/08/2011CA2442319C Carboxylic acid derivative and salt thereof
02/08/2011CA2431461C 1,5 benzothiazepines and their use as antihyperlipidemics
02/04/2011CA2710224A1 Novel dihydroindolone derivatives, method for production thereof and pharmaceutical compositions comprising said derivatives
02/03/2011WO2011014535A1 COMPOUNDS FOR THE REDUCTION OF β-AMYLOID PRODUCTION
02/03/2011WO2011014039A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same
02/03/2011WO2011013651A1 Bicyclic compound and use thereof for medical purposes